A Study of APG-1252 in Patients With Myelofibrosis Who Progressed After Initial Therapy
Clinical trial NCT04354727 · WITHDRAWN
Trial details
- NCT number
- NCT04354727
- Sponsor
- Ascentage Pharma Group Inc.
- Status
- WITHDRAWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-15
- Primary completion
- 2022-12-15
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.